Compare EVMN & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVMN | SOC |
|---|---|---|
| Founded | 2020 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 648.0M |
| IPO Year | 2025 | N/A |
| Metric | EVMN | SOC |
|---|---|---|
| Price | $17.01 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $39.33 | $17.00 |
| AVG Volume (30 Days) | 189.2K | ★ 10.8M |
| Earning Date | 12-11-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,000,000.00 | N/A |
| Revenue This Year | $89.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 160.00 | N/A |
| 52 Week Low | $13.89 | $3.72 |
| 52 Week High | $24.03 | $35.00 |
| Indicator | EVMN | SOC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.90 |
| Support Level | N/A | $7.31 |
| Resistance Level | N/A | $11.00 |
| Average True Range (ATR) | 0.00 | 1.08 |
| MACD | 0.00 | 0.64 |
| Stochastic Oscillator | 0.00 | 59.06 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.